Vertex Pharmaceuticals Incorporated (BIT:1VRTX)

Italy flag Italy · Delayed Price · Currency is EUR
418.25
0.00 (0.00%)
At close: Apr 11, 2025, 5:30 PM CET
11.91%
Market Cap 110.45B
Revenue (ttm) 10.64B
Net Income (ttm) -517.34M
Shares Out n/a
EPS (ttm) -2.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 6
Open 418.25
Previous Close 418.25
Day's Range 418.25 - 418.25
52-Week Range 363.20 - 486.10
Beta n/a
RSI 30.26
Earnings Date May 5, 2025

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 6,100
Stock Exchange Borsa Italiana
Ticker Symbol 1VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.